logo
Select company
Select metric
$ -418.48KNet Cash Flow - Financing
VS
Market
50
Sector
74
Industry
89
History
100
$ 26.83Close
$ 5.41 - $ 33.96 52-Week Range
Ticker Information

Ticker

PTHS

Company Name

PELTHOS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PELTHOS THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PTHS - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ -418.48K
3/31/2025$ 793.8K
12/31/2024$ 6.21M
9/30/2024$ 6.71M
6/30/2024$ 7.88M
3/31/2024$ 6.52M
12/31/2023$ 1.02M
12/31/2022$ 1.62M
12/31/2021$ 1.59M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PELTHOS THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 1.59M.
  • Over the past 5 years, PELTHOS THERAPEUTICS INC's average CF - Financing has been $ 3.55M.
  • The median CF - Financing for PELTHOS THERAPEUTICS INC during this period was $ 1.62M
  • PELTHOS THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 7.88M.
  • The lowest CF - Financing recorded by PELTHOS THERAPEUTICS INC in the same timeframe $ -418.48K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

PTHS - Net Cash Flow - Financing, Last 5 years

$ -418.48K

Minimum

Jun 30, 2025

$ 7.88M

Maximum

Jun 30, 2024

$ 3.55M

Average

$ 1.62M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.84M with a standard deviation of $ 119.25M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.84M
median$ 305K
std$ 119.25M